UBS raised the firm’s price target on McGraw Hill (MH) to $17 from $16 and keeps a Neutral rating on the shares. Shares are likely to rise following strong Q3 results and a guidance raise, driven by Higher Ed share gains and better-than-expected K-12 performance, with outlook implying upside into Q4 and a return to growth and margin expansion in fiscal 2027, the analyst tells investors in a research note. While execution has been solid and the stock offers an attractive normalized free cash flow yield near 9%, uncertainty around AI’s long-term impact may limit multiple expansion, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MH:
- McGraw Hill: Strong Q3 Beat, Upgraded Guidance, and Evergreen Model Growth Support Buy Rating
- Closing Bell Movers: Cisco falls 7% after earnings
- McGraw Hill reports Q3 adjusted EPS 28c, consensus 9c
- McGraw Hill raises FY26 revenue view to $2.07B-$2.09B from $2.03B-$2.06B
- MH Earnings this Week: How Will it Perform?
